Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Metabolic and safety issues for multiple sclerosis pharmacotherapy - opportunities for personalised medicine.
Cognitive rehabilitation of working memory in juvenile multiple sclerosis-effects on cognitive functioning, functional MRI and network related connectivity.
Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled study.
Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. (MOBILE)
MicroRNA regulation in experimental autoimmune encephalomyelitis in mice and marmosets resembles regulation in human multiple sclerosis lesions.
Determinants of the severity of comorbid migraine in multiple sclerosis.
Personality traits of patients with multiple sclerosis and their relationship with clinical characteristics.
Gait variability and disability in multiple sclerosis.
Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of K(V)1.3 Channel Blockers.
Regulated microRNAs in the CSF of patients with multiple sclerosis: A case-control study.
Fat-soluble vitamins as disease modulators in multiple sclerosis.
[New therapies in multiple sclerosis].
G protein-coupled receptor 30 contributes to improved remyelination after cuprizone-induced demyelination.
Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort.
Structural connectomics in brain diseases.
Early development of anti-natalizumab antibodies in MS patients.
ACUTE RETINAL NECROSIS AND IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN A NATALIZUMAB-TREATED PATIENT WITH MULTIPLE SCLEROSIS.
Antidepressant activity of fingolimod in mice.
Neuromodulation of lower limb motor control in restorative neurology.
Vitamin B12 deficiency mimicking NMO spectrum disorder.
Pediatric Multiple Sclerosis.
Asymptomatic Progressive Multifocal Leukoencephalopathy Associated with Natalizumab: Diagnostic Precision with MR Imaging.
Progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukaemia treated with alemtuzumab.
Experimental RRMS Therapy to Be Tested in a Phase 2b Clinical Trial
Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action.

Pages